Nova Mentis Life Science CorpCanadian Securities Exchange:NOVAView on OTC Pink - Current Information
- LAST PRICE0.0150
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0150/ 61
- Ask / Lots0.0200/ 361
- Open / Previous Close0.0000 / 0.0150
- Day Range---
- 52 Week Range
- Volume625
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | NOVA |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nova Mentis Life Science Corp | 2.2M | -1.8x | --- |
Vaxil Bio Ltd | 2.1M | -4.5x | --- |
GeneTether Therapeutics Inc | 1.7M | -2.1x | --- |
Glow Lifetech Corp | 1.8M | -0.9x | --- |
CVR Medical Corp | 2.0M | -0.6x | --- |
Many Bright Ideas Technologies Inc | 1.2M | -17.4x | --- |
Company Information
Nova Mentis Life Science Corp. is a Canadian biotechnology company. The Company is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. The Company has orphan drug designation in both the United States and European Union for the use of psilocybin in the treatment of fragile X syndrome (FXS). Its focus is to diagnose and treat debilitating chronic conditions that have unmet medical needs, such as autism spectrum disorder (ASD) and FXS. Its core scientific focus is on chronic neuroinflammatory conditions, which fall under three categories: neurodevelopmental, neurometabolic, and neurodegenerative. The Company operates in one segment, being research and development of psilocybin, and in one geographic area, being Canada, through its wholly owned subsidiaries, Nova Mentis Biotech Corp., and SwabAi Diagnostics Inc.
Contact Information
- Headquarters
- 700-838 West Hasting StreetVANCOUVER, BC, Canada V6C 0A6
- Phone
- 778-819-0244
- Fax
- 778-819-0244
Executives
- Executive Chairman of the Board
- Derek Ivany
- President, Chief Executive Officer, Director
- William Rascan
- Chief Financial Officer
- Rebecca Hudson
- Chief Operating Officer, Director
- Jacqueline Mcconnell
- Independent Director
- Stephen Glazer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 148.2M |
Nova Mentis Life Science Corp does not pay a dividend. | |
Beta | 0.68 |
EPS | $-0.01 |
Book Value | $-0.01 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
